FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SATAVAPTAN
异名/同义词AQUILDA
BENZAMIDE, N-(1,1-DIMETHYLETHYL)-4-((5'-ETHOXY-4-(2-(4-MORPHOLINYL)ETHOXY)-2'-OXOSPIRO(CYCLOHEXANE-1,3'-(3H)INDOL)-1'(2'H)-YL)SULFONYL)-3-METHOXY-, CIS-
BENZAMIDE, N-(1,1-DIMETHYLETHYL)-4-((CIS-5'-ETHOXY-4-(2-(4-MORPHOLINYL)ETHOXY)-2'-OXOSPIRO(CYCLOHEXANE-1,3'-(3H)INDOL)-1'(2'H)-YL)SULFONYL)-3-METHOXY-
N-TERT-BUTYL-4-(((1S,4S)-5'-ETHOXY-4-(2-MORPHOLIN-4-YLETHOXY)-2'-OXOSPIRO(CYCLOHEXANE-1,3'-INDOL)-1'(2'H)-YL)SULFONYL)-3-METHOXYBENZAMIDE
SATAVAPTAN
SATAVAPTAN [INN]
SATAVAPTAN [MART.]
SATAVAPTAN [WHO-DD]
SR121463
SR-121463
SR-121463A
CAS登记号185913-78-4
物质唯一标识(Unique Ingredient Identifier)AJS8S3P31H
分子式C33H45N3O8S
国际化合物标识(International Chemical Identifier,InChI)QKXJWFOKVQWEDZ-VCCCEUOBSA-N
SMILESS(N1C([C@]2(c3c1ccc(c3)OCC)CC[C@H](OCCN4CCOCC4)CC2)=O)(c5c(OC)cc(cc5)C(NC(C)(C)C)=O)(=O)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System